Yes, a significant number of medical professionals and health care providers trust Cologuard as a reliable option for their patients who are 45 and older and are at an average risk for colon cancer. Clinical acceptance of the test has grown substantially, with hundreds of thousands of providers recommending it as a viable first step for colorectal cancer screening. Many doctors appreciate Cologuard because it offers a non-invasive, stool-based screening method that can be performed in the privacy of the patient's home, which helps remove some of the barriers—such as the need for bowel preparation or the anxiety associated with colonoscopies—that often prevent patients from getting screened at all. For practices with limited access to gastroenterologists or for patients who are hesitant about traditional procedures, Cologuard is viewed as a high-performance, proven tool that helps bridge the screening gap and assists in meeting national public health goals. While doctors understand that a positive Cologuard result requires a follow-up diagnostic colonoscopy, they remain confident in its performance metrics and its role in an overall strategy to detect early-stage cancers or precancerous conditions in populations that might otherwise remain unmonitored.